Literature DB >> 19822655

A thiolase of Mycobacterium tuberculosis is required for virulence and production of androstenedione and androstadienedione from cholesterol.

Natasha M Nesbitt1, Xinxin Yang, Patricia Fontán, Irina Kolesnikova, Issar Smith, Nicole S Sampson, Eugenie Dubnau.   

Abstract

Mycobacterium tuberculosis, the causative agent of tuberculosis, is an intracellular pathogen that shifts to a lipid-based metabolism in the host. Moreover, metabolism of the host lipid cholesterol plays an important role in M. tuberculosis infection. We used transcriptional profiling to identify genes transcriptionally regulated by cholesterol and KstR (Rv3574), a TetR-like repressor. The fadA5 (Rv3546) gene, annotated as a lipid-metabolizing thiolase, the expression of which is upregulated by cholesterol and repressed by KstR, was deleted in M. tuberculosis H37Rv. We demonstrated that fadA5 is required for utilization of cholesterol as a sole carbon source in vitro and for full virulence of M. tuberculosis in the chronic stage of mouse lung infection. Cholesterol is not toxic to the fadA5 mutant strain, and, therefore, toxicity does not account for its attenuation. We show that the wild-type strain, H37Rv, metabolizes cholesterol to androst-4-ene-3,17-dione (AD) and androsta-1,4-diene-3,17-dione (ADD) and exports these metabolites into the medium, whereas the fadA5 mutant strain is defective for this activity. We demonstrate that FadA5 catalyzes the thiolysis of acetoacetyl-coenzyme A (CoA). This catalytic activity is consistent with a beta-ketoacyl-CoA thiolase function in cholesterol beta-oxidation that is required for the production of androsterones. We conclude that the attenuated phenotype of the fadA5 mutant is a consequence of disrupted cholesterol metabolism that is essential only in the persistent stage of M. tuberculosis infection and may be caused by the inability to produce AD/ADD from cholesterol.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19822655      PMCID: PMC2798224          DOI: 10.1128/IAI.00893-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

2.  Direct observation of rapid internalization and intracellular transport of sterol by macrophage foam cells.

Authors:  Daniel Wüstner; Mousumi Mondal; Ira Tabas; Frederick R Maxfield
Journal:  Traffic       Date:  2005-05       Impact factor: 6.215

3.  The Mycobacterium tuberculosis PhoPR two-component system regulates genes essential for virulence and complex lipid biosynthesis.

Authors:  Shaun B Walters; Eugenie Dubnau; Irina Kolesnikova; Francoise Laval; Mamadou Daffe; Issar Smith
Journal:  Mol Microbiol       Date:  2006-04       Impact factor: 3.501

4.  responses of mycobacterium tuberculosis to growth in the mouse lung.

Authors:  Eugenie Dubnau; John Chan; V P Mohan; Issar Smith
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

Review 5.  The thiolase superfamily: condensing enzymes with diverse reaction specificities.

Authors:  Antti M Haapalainen; Gitte Meriläinen; Rik K Wierenga
Journal:  Trends Biochem Sci       Date:  2005-12-13       Impact factor: 13.807

6.  A gene cluster encoding cholesterol catabolism in a soil actinomycete provides insight into Mycobacterium tuberculosis survival in macrophages.

Authors:  Robert Van der Geize; Katherine Yam; Thomas Heuser; Maarten H Wilbrink; Hirofumi Hara; Matthew C Anderton; Edith Sim; Lubbert Dijkhuizen; Julian E Davies; William W Mohn; Lindsay D Eltis
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-30       Impact factor: 11.205

Review 7.  Who puts the tubercle in tuberculosis?

Authors:  David G Russell
Journal:  Nat Rev Microbiol       Date:  2006-12-11       Impact factor: 60.633

8.  The kinetic mechanism and properties of the cytoplasmic acetoacetyl-coenzyme A thiolase from rat liver.

Authors:  B Middleton
Journal:  Biochem J       Date:  1974-04       Impact factor: 3.857

9.  Mechanistic studies on beta-ketoacyl thiolase from Zoogloea ramigera: identification of the active-site nucleophile as Cys89, its mutation to Ser89, and kinetic and thermodynamic characterization of wild-type and mutant enzymes.

Authors:  S Thompson; F Mayerl; O P Peoples; S Masamune; A J Sinskey; C T Walsh
Journal:  Biochemistry       Date:  1989-07-11       Impact factor: 3.162

10.  The HHpred interactive server for protein homology detection and structure prediction.

Authors:  Johannes Söding; Andreas Biegert; Andrei N Lupas
Journal:  Nucleic Acids Res       Date:  2005-07-01       Impact factor: 16.971

View more
  89 in total

1.  Pathway profiling in Mycobacterium tuberculosis: elucidation of cholesterol-derived catabolite and enzymes that catalyze its metabolism.

Authors:  Suzanne T Thomas; Brian C VanderVen; David R Sherman; David G Russell; Nicole S Sampson
Journal:  J Biol Chem       Date:  2011-11-01       Impact factor: 5.157

Review 2.  The Minimal Unit of Infection: Mycobacterium tuberculosis in the Macrophage.

Authors:  Brian C VanderVen; Lu Huang; Kyle H Rohde; David G Russell
Journal:  Microbiol Spectr       Date:  2016-12

3.  Anoxic androgen degradation by the denitrifying bacterium Sterolibacterium denitrificans via the 2,3-seco pathway.

Authors:  Po-Hsiang Wang; Chang-Ping Yu; Tzong-Huei Lee; Ching-Wen Lin; Wael Ismail; Shiaw-Pyng Wey; An-Ti Kuo; Yin-Ru Chiang
Journal:  Appl Environ Microbiol       Date:  2014-03-21       Impact factor: 4.792

Review 4.  Metabolic Perspectives on Persistence.

Authors:  Travis E Hartman; Zhe Wang; Robert S Jansen; Susana Gardete; Kyu Y Rhee
Journal:  Microbiol Spectr       Date:  2017-01

Review 5.  The tuberculosis drug discovery and development pipeline and emerging drug targets.

Authors:  Khisimuzi Mdluli; Takushi Kaneko; Anna Upton
Journal:  Cold Spring Harb Perspect Med       Date:  2015-01-29       Impact factor: 6.915

6.  Designing novel inhibitors against Mycobacterium tuberculosis FadA5 (acetyl-CoA acetyltransferase) by virtual screening of known anti-tuberculosis (bioactive) compounds.

Authors:  Atul Kumar Jaiswal; Syed Hussain Abbas Husaini; Amarjeet Kumar; Naidu Subbarao
Journal:  Bioinformation       Date:  2018-06-30

7.  Cholesterol catabolism by Mycobacterium tuberculosis requires transcriptional and metabolic adaptations.

Authors:  Jennifer E Griffin; Amit K Pandey; Sarah A Gilmore; Valerie Mizrahi; John D McKinney; Carolyn R Bertozzi; Christopher M Sassetti
Journal:  Chem Biol       Date:  2012-02-24

8.  FadA5 a thiolase from Mycobacterium tuberculosis: a steroid-binding pocket reveals the potential for drug development against tuberculosis.

Authors:  Christin M Schaefer; Rui Lu; Natasha M Nesbitt; Johannes Schiebel; Nicole S Sampson; Caroline Kisker
Journal:  Structure       Date:  2014-12-04       Impact factor: 5.006

9.  Deciphering the transcriptional regulation of cholesterol catabolic pathway in mycobacteria: identification of the inducer of KstR repressor.

Authors:  Esther García-Fernández; Francisco Javier Medrano; Beatriz Galán; José Luis García
Journal:  J Biol Chem       Date:  2014-05-06       Impact factor: 5.157

10.  A highly conserved mycobacterial cholesterol catabolic pathway.

Authors:  Esther García-Fernández; Daniel J Frank; Beatriz Galán; Petrea M Kells; Larissa M Podust; José L García; Paul R Ortiz de Montellano
Journal:  Environ Microbiol       Date:  2013-03-14       Impact factor: 5.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.